订购/客服:400-623-8666 | 021-51328699
通过类别精选:
手性药用中间体
手性催化剂,配体和试剂
手性助剂
手性砌块
拆分试剂

COA查询:
产品编号 CAS号 项目名称规格 分子式 加入购物车
R859587 1429939-35-4 (+)-1,13-双[二(3,5-二甲基苯基)膦]-(5AR,8AR,14aR)-5a,6,7,8,8a,9-六氢-5-H-[1]苯并吡喃, 98%purity,99%e.e.
(R,R,R)-(+)-XYL-SKP, 98%purity,99%e.e.
C52H54O2P2
B804592 112246-73-8 (+)二异松蒎基氯硼烷, 60% in Heptane,ca. 1.7mol/L
(+)-B-Chlorodiisopinocampheylborane, 60% in Heptane,ca. 1.7mol/L
C20H34BCl
S859594 1439556-82-7 (-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 98%purity,99%e.e.
(S,S,S)-(-)-Ph-SKP, 98%purity,99%e.e.
C44H38O2P2
S859586 1429939-31-0 (-)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 98%purity,99%e.e.
(S,S,S)-(-)-Xyl-SKP, 98%purity,99%e.e.
C52H54O2P2
S859613 1548897-80-8 (-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 98%purity,99%e.e.
(S,S,S)-(-)-Tol-SKP, 98%purity,99%e.e.
C48H46O2P2
R854263 1372719-95-3 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C47H59O4P
R854260 1297613-73-0 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C37H27O4P
R854262 1297613-74-1 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C37H27O4P
R854269 1372719-93-1 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C45H31O4P
R854255 1297613-72-9 (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C29H23O4P
R853903 930784-57-9 (11aR)-10,11,12,13-Tetrahydro-N,N,3,7-tetramethyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%
(11aR)-10,11,12,13-Tetrahydro-N,N,3,7-tetramethyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%
C21H24NO2P
R853904 500997-69-3 (11aR)-10,11,12,13-Tetrahydro-N,N-bis[(1R)-1-phenylethyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%,≥99% e.e.
(11aR)-10,11,12,13-Tetrahydro-N,N-bis[(1R)-1-phenylethyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%,≥99% e.e.
C33H32NO2P
R854400 (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C37H39O4P
R854398 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e.
(11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e.
C49H31O4P
R854276 1801196-27-9 (11aR)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-3,7-Bis(2,​4,​6-​trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C35H35O4P
R854406 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C29H19Cl4O4P
R854259 1297613-75-2 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
(11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e.
C33H31O4P
R854402 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C31H21F6O4P
R854397 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C29H21Cl2O4P
R854404 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
(11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e.
C31H27O6P
首页|网站使用条款|隐私政策|关于我们|网站地图
Copyright © 2014 Macklin Inc. - All rights reserved.
沪ICP备14004368号
   
请填写购买数量! 您已收藏过此产品! 成功从购物车删除! 成功清楚购物车!